Literature DB >> 22434264

Suppressive effects of N-acetyl-D-glucosamine on rheumatoid arthritis mouse models.

Kazuo Azuma1, Tomohiro Osaki, Takashi Wakuda, Takeshi Tsuka, Tomohiro Imagawa, Yoshiharu Okamoto, Saburo Minami.   

Abstract

We examined effects of N-acetyl-D: -glucosamine (GlcNAc) on rheumatoid arthritis (RA) mouse models and effects of GlcNAc and glucosamine hydrochloride (GlcN) on several serum cytokine productions in RA mouse models. SKG/jcl mice were divided into control, GlcNAc, and GlcN groups. For 56 days, the control group received normal food, the GlcNAc group received 0.5 % GlcNAc-containing food, and the GlcN group received 0.5 % GlcN-containing food. GlcNAc and GlcN equally suppressed arthritis scores and histopathological scores compared to the control group. In the GlcN group, serum tumor necrosis factor-α and interleukin (IL)-6 concentrations were significantly decreased compared to the control group. In the GlcNAc group, serum IL-10, transforming growth factor β-1, and IL-2 concentrations were significantly increased compared to the control group. Our results indicated that GlcNAc also has suppressive effects on experimental RA in mouse models. The results of serum cytokine concentrations suggested that compared to GlcN, GlcNAc has a different suppressive mechanism in experimental RA models.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22434264     DOI: 10.1007/s10753-012-9459-0

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  14 in total

Review 1.  Rheumatoid arthritis.

Authors:  Gene-Siew Ngian
Journal:  Aust Fam Physician       Date:  2010-09

2.  Glucosamine modulates IL-1-induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF-kappa B pathway.

Authors:  J N Gouze; A Bianchi; P Bécuwe; M Dauça; P Netter; J Magdalou; B Terlain; K Bordji
Journal:  FEBS Lett       Date:  2002-01-16       Impact factor: 4.124

3.  Preventive actions of a high dose of glucosamine on adjuvant arthritis in rats.

Authors:  J Hua; S Suguro; S Hirano; K Sakamoto; I Nagaoka
Journal:  Inflamm Res       Date:  2005-03       Impact factor: 4.575

4.  Essential roles of Toll-like receptor-4 signaling in arthritis induced by type II collagen antibody and LPS.

Authors:  Eun-Kyu Lee; Sang-Mee Kang; Doo-Jin Paik; Jung Mogg Kim; Jeehee Youn
Journal:  Int Immunol       Date:  2005-01-31       Impact factor: 4.823

Review 5.  Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy.

Authors:  J W Anderson; R J Nicolosi; J F Borzelleca
Journal:  Food Chem Toxicol       Date:  2005-02       Impact factor: 6.023

6.  Evaluation of the suppressive actions of glucosamine on the interleukin-1beta-mediated activation of synoviocytes.

Authors:  J Hua; K Sakamoto; T Kikukawa; C Abe; H Kurosawa; I Nagaoka
Journal:  Inflamm Res       Date:  2007-10       Impact factor: 4.575

Review 7.  Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis.

Authors:  Kiran Nistala; Lucy R Wedderburn
Journal:  Rheumatology (Oxford)       Date:  2009-03-05       Impact factor: 7.580

8.  Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment.

Authors:  C Hawkey; A Kahan; K Steinbrück; C Alegre; E Baumelou; B Bégaud; J Dequeker; H Isomäki; G Littlejohn; J Mau; S Papazoglou
Journal:  Br J Rheumatol       Date:  1998-09

9.  Differential metabolic effects of glucosamine and N-acetylglucosamine in human articular chondrocytes.

Authors:  A R Shikhman; D C Brinson; J Valbracht; M K Lotz
Journal:  Osteoarthritis Cartilage       Date:  2009-03-24       Impact factor: 6.576

10.  Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice.

Authors:  Noriko Sakaguchi; Takeshi Takahashi; Hiroshi Hata; Takashi Nomura; Tomoyuki Tagami; Sayuri Yamazaki; Toshiko Sakihama; Takaji Matsutani; Izumi Negishi; Syuichi Nakatsuru; Shimon Sakaguchi
Journal:  Nature       Date:  2003-11-27       Impact factor: 49.962

View more
  15 in total

1.  Use of glucosamine and chondroitin supplements in relation to risk of colorectal cancer: Results from the Nurses' Health Study and Health Professionals follow-up study.

Authors:  Elizabeth D Kantor; Xuehong Zhang; Kana Wu; Lisa B Signorello; Andrew T Chan; Charles S Fuchs; Edward L Giovannucci
Journal:  Int J Cancer       Date:  2016-07-18       Impact factor: 7.396

2.  Glucosamine Use, Inflammation, and Genetic Susceptibility, and Incidence of Type 2 Diabetes: A Prospective Study in UK Biobank.

Authors:  Hao Ma; Xiang Li; Tao Zhou; Dianjianyi Sun; Zhaoxia Liang; Ying Li; Yoriko Heianza; Lu Qi
Journal:  Diabetes Care       Date:  2020-01-27       Impact factor: 19.112

3.  Collagen-induced arthritis: severity and immune response attenuation using multivalent N-acetyl glucosamine.

Authors:  J Richter; K Capková; V Hříbalová; L Vannucci; I Danyi; M Malý; A Fišerová
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

4.  Specialty supplement use and biologic measures of oxidative stress and DNA damage.

Authors:  Elizabeth D Kantor; Cornelia M Ulrich; Robert W Owen; Peter Schmezer; Marian L Neuhouser; Johanna W Lampe; Ulrike Peters; Danny D Shen; Thomas L Vaughan; Emily White
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-08-05       Impact factor: 4.254

5.  Hypoxia-Induced Neuroinflammation and Learning-Memory Impairments in Adult Zebrafish Are Suppressed by Glucosamine.

Authors:  Yunkyoung Lee; Sujeong Lee; Ji-Won Park; Ji-Sun Hwang; Sang-Min Kim; In Kyoon Lyoo; Chang-Joong Lee; Inn-Oc Han
Journal:  Mol Neurobiol       Date:  2018-03-27       Impact factor: 5.590

6.  Associations between glucosamine and chondroitin supplement use and biomarkers of systemic inflammation.

Authors:  Elizabeth D Kantor; Johanna W Lampe; Sandi L Navarro; Xiaoling Song; Ginger L Milne; Emily White
Journal:  J Altern Complement Med       Date:  2014-04-16       Impact factor: 2.579

7.  Glucosamine use and risk of colorectal cancer: results from the Cancer Prevention Study II Nutrition Cohort.

Authors:  Elizabeth D Kantor; Christina C Newton; Edward L Giovannucci; Marjorie L McCullough; Peter T Campbell; Eric J Jacobs
Journal:  Cancer Causes Control       Date:  2018-02-06       Impact factor: 2.506

8.  Glucosamine and Chondroitin Use in Relation to C-Reactive Protein Concentration: Results by Supplement Form, Formulation, and Dose.

Authors:  Elizabeth D Kantor; Kelli O'Connell; Mengmeng Du; Chao Cao; Xuehong Zhang; Dong Hoon Lee; Yin Cao; Edward L Giovannucci
Journal:  J Altern Complement Med       Date:  2020-12-07       Impact factor: 2.579

9.  Glucosamine and Chondroitin Supplements and Risk of Colorectal Adenoma and Serrated Polyp.

Authors:  Dong Hoon Lee; Chao Cao; Yin Cao; Edward L Giovannucci; Elizabeth D Kantor; Xiaoyu Zong; Xuehong Zhang; Kelli O'Connell; Mingyang Song; Kana Wu; Mengmeng Du
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-10-14       Impact factor: 4.254

10.  Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV.

Authors:  Leila B Giron; Clovis S Palmer; Qin Liu; Xiangfan Yin; Emmanouil Papasavvas; Radwa Sharaf; Behzad Etemad; Mohammad Damra; Aaron R Goldman; Hsin-Yao Tang; Rowena Johnston; Karam Mounzer; Jay R Kostman; Pablo Tebas; Alan Landay; Luis J Montaner; Jeffrey M Jacobson; Jonathan Z Li; Mohamed Abdel-Mohsen
Journal:  Nat Commun       Date:  2021-06-29       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.